Logo

Hyalubrix® for TEMPORARY SYNOVIAL FLUID REPLACEMENT reducing pain symptoms and improving joint functionality1

Composition

Hyaluronic acid sodium salt (30mg/2mL) obtained by bacterial fermentation from a fraction of high molecular weight1

Available Presentation

Box containing 1 pre-filled syringe sealed in a blister1

Indications

HYALUBRIX® is indicated for the treatment of pain and the improvement of joint functionality in patients affected by degenerative or mechanical arthropathy of the knee, hip, shoulder, ankle and trapeziometacarpal joint1

Dosage & Administration

Cycle of 3 intra-articular injections, at weekly intervals.1

Available PRESENTATION

Box containing 1 pre-filled syringe.

PRODUCT PORTFOLIO

VISCOSUPPLEMENTATION

Medical Devices CE0459.
Read the instructions for use carefully.

References:
1. HYALUBRIX® Patient Information Leaflet

You are about to leave fidiajointcare.com

All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Proceed